Paclitaxel as a radiation sensitizer for locally advanced pancreatic cancerSAFRAN, Howard; RATHORE, Ritesh.Critical reviews in oncology/hematology. 2002, Vol 43, Num 1, pp 57-62, issn 1040-8428Article

Paclitaxel and concurrent Radiation in upper gastrointestinal cancersCONSTANTINOU, Maria; TSAI, James Y; SAFRAN, Howard et al.Cancer investigation. 2003, Vol 21, Num 6, pp 887-896, issn 0735-7907, 10 p.Article

Radiofrequency ablation: A medical oncology perspectiveZAHRAH, George; SAFRAN, Howard.Seminars in interventional radiology. 2003, Vol 20, Num 4, pp 275-277, issn 0739-9529, 3 p.Article

Combined modality therapy for pancreatic cancerTSAI, James Y; IANNITTI, David A; SAFRAN, Howard et al.Seminars in oncology. 2003, Vol 30, Num 4, pp 71-79, issn 0093-7754, 9 p., SUP9Article

NEOADJUVANT BEVACIZUMAB, OXALIPLATIN, 5-FLUOROURACIL, AND RADIATION FOR RECTAL CANCERDIPETRILLO, Tom; PRICOLO, Victor; KHURSHID, Humera et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 1, pp 124-129, issn 0360-3016, 6 p.Article

Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer: A Survival Analysis of a Brown University Oncology Group Phase II StudyBIRNBAUM, Ariel; DIPETRILLO, Thomas; FOLLETT, Nancy et al.American journal of clinical oncology. 2014, Vol 37, Num 2, pp 162-166, issn 0277-3732, 5 p.Article

FAILURE TO ADHERE TO PROTOCOL SPECIFIED RADIATION THERAPY GUIDELINES WAS ASSOCIATED WITH DECREASED SURVIVAL IN RTOG 9704—A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREASABRAMS, Ross A; WINTER, Kathryn A; WILLETT, Christopher G et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 2, pp 809-816, issn 0360-3016, 8 p.Article

Clinical research in pancreatic cancer: The radiation therapy oncology group trialsWILLETT, Christopher G; SAFRAN, Howard; ABRAMS, Ross A et al.International journal of radiation oncology, biology, physics. Supplement. 2003, Vol 56, Num 4, pp 31-37, issn 0145-1464, 7 p.Article

Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411CRANE, Christopher H; WINTER, Kathryn; REGINE, William F et al.Journal of clinical oncology. 2009, Vol 27, Num 25, pp 4096-4102, issn 0732-183X, 7 p.Article

Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation : A Prospective Validation by RTOG 9704BERGER, Adam C; GARCIA, Miguel; HOFFMAN, John P et al.Journal of clinical oncology. 2008, Vol 26, Num 36, pp 5918-5922, issn 0732-183X, 5 p.Article

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trialFUCHS, Charles S; TOMASEK, Jiri; MELICHAR, Bohuslav et al.Lancet (British edition). 2014, Vol 383, Num 9911, pp 31-39, issn 0140-6736, 9 p.Article

THE INFLUENCE OF TOTAL NODES EXAMINED, NUMBER OF POSITIVE NODES, AND LYMPH NODE RATIO ON SURVIVAL AFTER SURGICAL RESECTION AND ADJUVANT CHEMORADIATION FOR PANCREATIC CANCER: A SECONDARY ANALYSIS OF RTOG 9704SHOWALTER, Timothy N; WINTER, Kathryn A; BERGER, Adam C et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 5, pp 1328-1335, issn 0360-3016, 8 p.Article

Human aspartyl (asparaginyl) β-hydroxylase monoclonal antibodies: Potential biomarkers for Pancreatic carcinomaPALUMBO, Kevin S; WANDS, Jack R; SAFRAN, Howard et al.Pancreas. 2002, Vol 25, Num 1, pp 39-44, issn 0885-3177Article

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease ProgressionCRANE, Christopher H; VARADHACHARY, Gauri R; DAS, Prajnan et al.Journal of clinical oncology. 2011, Vol 29, Num 22, pp 3037-3043, issn 0732-183X, 7 p.Article

A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving boneAKERLEY, Wallace; BUTERA, James; LEONE, Louis et al.Cancer. 2002, Vol 94, Num 6, pp 1654-1660, issn 0008-543XArticle

Paclitaxel and concurrent radiation for locally advanced pancreatic cancerSAFRAN, Howard; MOORE, Todd; VAKHARIA, Jamsheed et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 5, pp 1275-1279, issn 0360-3016Article

Paclitaxel, cisplatin, and concurrent radiation for esophageal cancerSAFRAN, Howard; GAISSERT, Henning; AKERMAN, Paul et al.Cancer investigation. 2001, Vol 19, Num 1, pp 1-7, issn 0735-7907Article

Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinomaSHIMODA, Masafumi; TOMIMARU, Yoshito; CHARPENTIER, Kevin P et al.Journal of hepatology. 2012, Vol 56, Num 5, pp 1129-1135, issn 0168-8278, 7 p.Article

Percutaneous Radiofrequency Ablation of Painful Osseous Metastases: A Multicenter American College of Radiology Imaging Network TrialDUPUY, Damian E; DAWEI LIU; HARTFEIL, Donna et al.Cancer. 2010, Vol 116, Num 4, pp 989-997, issn 0008-543X, 9 p.Article

Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma : A Randomized Controlled TrialREGINE, William F; WINTER, Kathryn A; HADDOCK, Michael G et al.JAMA, the journal of the American Medical Association. 2008, Vol 299, Num 9, issn 0098-7484, 1019-1026, 1066-1067 [10 p.]Article

Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancerAKERLEY, Wallace; SAFRAN, Howard; ZANER, Ken et al.Cancer. 2006, Vol 107, Num 5, pp 1050-1054, issn 0008-543X, 5 p.Article

Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: A phase I trialSAFRAN, Howard; DIPETRILLO, Thomas; IANNITTI, David et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 1, pp 137-141, issn 0360-3016Article

Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinomaSAFRAN, Howard; STEINHOFF, Margaret; PASQUARIELLO, Terese et al.American journal of clinical oncology. 2001, Vol 24, Num 5, pp 496-499, issn 0277-3732Conference Paper

Pulmonary radiofrequency ablation : Long-term safety and efficacy in 153 patientsSIMON, Caroline J; DUPOY, Damian E; DIPETRILLO, Thomas A et al.Radiology. 2007, Vol 243, Num 1, pp 268-275, issn 0033-8419, 8 p.Article